Recommendations for Initiation of SGLT2i in Patients with HF and T2D

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/af/98/65/af9865af-1403-02a5-c6b3-9644de7bc0ff/mza_18001081538756709646.png/600x600bb.jpg

Canadian Heart Failure Society

chfs

12 episodes

9 months ago

Welcome to the Canadian Heart Failure Society (CHFS) podcast channel. The CHFS provides a forum for cardiovascular professionals to exchange ideas, advance knowledge, improve practice and care delivery in the prevention, diagnosis, and management of all Heart Failure phases and complications. Visit https://heartfailure.ca/ to learn more.

Non-Profit

Business

RSS

All content for Canadian Heart Failure Society is the property of chfs and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Non-Profit

Business

Recommendations for Initiation of SGLT2i in Patients with HF and T2D

Canadian Heart Failure Society

14 minutes 22 seconds

3 years ago

Recommendations for Initiation of SGLT2i in Patients with HF and T2D

In this episode presented by the Canadian Heart Failure Society (CHFS) entitled “Recommendations for Initiation of SGLT2i in Patients with HF and T2D” presented by Dr. Grace Chua, we will focus on the initiation of SGLT2i in patients with HFrEF and Type 2 Diabetes and we will review practical tips and key questions to a patient case. An on-demand version of the 30-minute episode presented on the same topic is available right now at www.imedicus.ca/hf21. To learn more about the Canadian Heart Failure Society and find out more about upcoming programs and initiatives, visit www.heartfailure.ca. We hope you enjoy this episode! This program was made possible through grants from Novartis and BI-Lilly Alliance.